Affiliation:
1. Department of Anesthesiology, Sheba Medical Centre, Ramat Gan 5262000, Israel
2. School of Medicine, Tel Aviv University, Tel Aviv 6139001, Israel
3. Department of Cardiac Surgery, Leviev Cardiothoracic and Vascular Centre, Sheba Medical Centre, Ramat Gan 5262000, Israel
Abstract
With the growing number of left ventricular assist device (LVAD) recipients requiring non-cardiac surgery and the limited availability of cardiac anesthesiologists, our study reviewed non-cardiac surgeries in HeartMate III patients with LVAD at our institution. We focused on anesthesiologist roles, detailing patient characteristics, anesthetic management, and outcomes and identifying improvement opportunities in this specialized care setting. A retrospective chart review was conducted of all patients with LVAD who underwent non-cardiac surgery at our institution between 2017 and 2022. Patient demographics, surgical characteristics, anesthetic management, and 30-day mortality rates were also assessed. A total of 23 patients were identified, with 17 (73.9%) males and a median age of 61 [53.5, 67.5] years. Cardiac anesthesiologists were present in nine (39.1%) cases. Elective surgeries were more common (73.9%), with intermediate-risk surgeries accounting for 52.2% of all surgeries. General anesthesia was administered to 18 patients (78.3%), with a median duration of 40 [24, 63.5] min. A single patient required reoperation because of bleeding, and two patients (8.7%) experienced 30-day mortality. Despite guidelines lacking detail, involving non-cardiac anesthesiologists in certain cases is essential. Sharing our experience aims to enhance the evolving discourse on non-cardiac surgeries for patients with LVAD, improving their outcomes and safety.
Reference21 articles.
1. Efficacy and Complication Profiles of Left Ventricular Assist Devices in Adult Heart Failure Management: A Systematic Review and Meta-Analysis;Curr. Probl. Cardiol.,2024
2. A Rising Hope of an Artificial Heart: Left Ventricular Assisted Device—Outcome, Convenience, and Quality of Life;Thiha;Cureus,2019
3. Five-year outcomes following left ventricular assist device implantation in England;Bottle;Open Heart.,2021
4. Five-Year Outcomes in Patients with Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial;Mehra;JAMA,2022
5. A Fully Magnetically Levitated Left Ventricular Assist Device—Final Report;Mehra;N. Engl. J. Med.,2019